Nephroprotection of valsartan on function and morphology in spontaneously hypertensive rats
ZHU Yanjuan ,FU Chensheng ,JIANG Jingen,et al.
(Division of Nephrology,Zhongshan Hospital,Shanghai Medical University,Shanghai 200032,China)
Abstract:Objective To study the effect of vaIsartan on renal structure and function in spontaneously hypertensive rat(SHR) and explore its mechanism.Methods Twenty SHRs were gorged with benazepril (10 mg·kg-1·d-1),valsartan (10mg·kg-1·d-1) or water respectively for 12 weeks in the treating and control groups.The blood pressure,proteinuria and nitric oxide (NO) were assessed,and renal tissues were examined routinely by light and electron microscopy.The levels of TGF-β1 mRNA were detected by RT-PCR.Results The excretion of proteinuria significantly decreased in the treating groups compared to control group(P<0.01),and was further lower in valsartan group(P<0.05).The NO levels of serum and urine in the treating groups were significantly higher than that in the control(P<0.01).The levels of TGF-β1 mRNA were down-regulated in the treating groups(P<0.001),and further lower in valsartan group(P<0.001).Severe hypertrophy and sclerosis on the walls of arterioles,narrow,even occlusion in the lumina of these arterioles and hyalinization in some glomeruli were seen in control SHR.Benazepril and valsartan could attenuate the above injuries of small arteries.There was no hyalinization in glomernli and arterioles.Conclusions Valsartan reduces the extent of proteinuria and attenuates functional and structural injuries induced by hypertension.Angiotensin Ⅱ,NO and TGF-β1 may be involved in the mechanism concerned.
Keywords:Rat,spontaneously hypertensive;Angiotensin Ⅱ receptor antagonist;Nitric oxide;Transforming growth factor-β1;Renal arterial sclerosis参考文献:
[1]Scott E,Campbell K,Laxmansa C.Angiotensin Ⅱ stimulated expression of transforming growth factor-β1 in cardiac fibroblasts and myofibroblasts.J Mol Cell Cardiol,1997,29:1947-1958.
[2]Nordlander M,Havu N.Effects of chronic felodipinc treatment on renal function and morphology in SHR.Kidney Int,1992,4-1 Supple 36:S100-S105.
[3]Maschio G,Albeti D,Janin G,et al.For the AIPRI Study Group.Effect of the angiotensin-converting enzyme inhibitor benazepril on the progression of chronic renal failure.N Engl J Med,1996,334:939-945.
[4]Remuzzi A,Fassi A,Sangalli F,et al.Prevention of renal injury in diabetic MWF rats by angiotensin Ⅱ antagonist.Exp Nephol,1998,6:28-38.
[5]Rosaura M,Cid JN,Garcia RM,et al.Losartan reduces phenylephrine constrictor response in aortic rings from spontaneously hypertensive rats:role of nitric oxide and angiotensin Ⅱ type 2 receptors.Hypertension,1996,28:967-972.
[6]Madrid MI,Garcia S M,Tornal J,et al.Interactions between nitric oxide and angiotensin Ⅱ on renal cortical and papillary blood flow.Hypertension,1997,30:1175-1182.
[7]Wu L L,Cox A,Roe C J,et al.Transforming growth factor β1 and renal injury following subtotal nephrectomy in the rat:role of the renin angioten system.Kidney Int,1997,51:1553-1567.
收稿日期:1999-11-10
